Response to the letter of Gifford and Moss
- PMID: 22180002
- DOI: 10.1002/ibd.22852
Response to the letter of Gifford and Moss
Comment on
-
Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trial.Inflamm Bowel Dis. 2011 Sep;17(9):1874-81. doi: 10.1002/ibd.21570. Epub 2011 Jan 6. Inflamm Bowel Dis. 2011. PMID: 21830265 Clinical Trial.
-
Comment on Moshkovska et al.Inflamm Bowel Dis. 2013 Feb;19(2):E19. doi: 10.1002/ibd.22851. Inflamm Bowel Dis. 2013. PMID: 22179973 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical